Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort
Cancers · 18.11.2026 · 18 (22) · 3690
DOI: 10.3390/cancers18223690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.11.2026. Verfasst von Corinne Hübers und 8 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pleomorphic dermal sarcoma (PDS) is a rare, cutaneous sarcoma predominantly affecting sun-exposed skin in elderly patients. Surgical excision remains the mainstay of treatment, but evidence on optimal management and long-term outcomes is limited.
Methods
We retrospectively analyzed 1069 patients diagnosed with PDS between 2009 and 2025 using data from the Baden-Württemberg Cancer Registry, Germany. Patient characteristics, surgical management, resection status, and preceding malignancies were evaluated. Temporal surgical trends were assessed using multivariable logistic regression. Overall survival (OS) was analyzed using Kaplan–Meier estimates and multivariable Cox regression.
Results
Median age was 82 years, and 83.7% of patients were male. The hair-bearing scalp was the most frequent tumor site (55.0%). Among 449 patients with documented surgical procedures, 82.0% underwent micrographically controlled surgery (MGC), with increasing use over time (adjusted OR per year, 1.19; 95% CI, 1.11–1.29). R0-resections were comparable between MGC and conventional resection (75.7% vs. 71.6%). Among 679 patients evaluated for preceding malignancies, 39.7% had a documented cancer history, including 4.4% with hematologic malignancies. Among 723 patients with reliable follow-up, median OS was 72.4 months (95% CI, 61.3–82.1). Mortality was strongly associated with age, but not anatomical tumor site. Surgical approach was not significantly associated with OS after adjustment (MGC vs. conventional resection: HR, 1.49; 95% CI, 0.95–2.3; p = 0.083).
Conclusions
This large registry-based study provides real-world evidence on PDS management and prognosis. The increasing adoption of MGC supports its growing role in clinical practice, while the high frequency of preceding malignancies highlights the complex oncological history of patients with PDS.
Zitieren
APA
Hübers, C., Utikal, J. S., Wohlfeil, S. A., Surovtsova, I., Oswald, C., Bauer-Auch, C., Braun, A., Hereth, H., & Morakis, P. (2026). Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort. Cancers, 18(22), 3690. https://doi.org/10.3390/cancers18223690
Vancouver
Hübers C, Utikal JS, Wohlfeil SA, Surovtsova I, Oswald C, Bauer-Auch C, et al. Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort. Cancers. 2026;18(22):3690. doi:10.3390/cancers18223690
BibTeX
@article{Hbers2026,
author = {Hübers, Corinne and Utikal, Jochen S. and Wohlfeil, Sebastian A. and Surovtsova, Irina and Oswald, Cigdem and Bauer-Auch, Christiane and Braun, Amelie and Hereth, Heike and Morakis, Philipp},
title = {Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3690},
doi = {10.3390/cancers18223690}
}
EUVIMED